Table 2. Analysis of genotypes and alleles in the IFNL4, MxA, and MxB genes between HBV infected persons and controls.

SNP	HBV patients (N = 448)	Controls (N = 448)	P-value	OR (95% CI)
rs11322783 (IFNL4)
Genotype
ΔG	1	1	0.479	1.000 [0.053–19.04]
ΔG/T	40	25	0.071	1.659 [1.000–2.812]
TT	407	422	0.075	0.612 [0.368–1.000]
Allele
ΔG	42	27	0.086	1.583 [0.970–2.566]
T	854	869		0.632 [0.390–1.031]
rs117648444 (IFNL4)
Genotype
AA	0	0	–	–
AG	11	7	0.475	1.586 [0.627–4.119]
GG	437	441	0.475	0.631 [0.243–1.595]
Allele
A	11	7	0.477	1.579 [0.630–4.115]
G	885	889		0.634 [0.243–1.588]
rs2071430 (MxA)
Genotype
GG	230	217	0.423	1.123 [0.867–1.456]
GT	168	188	0.195	0.830 [0.632–1.087]
TT	50	43	0.511	1.183 [0.767–1.801]
Allele
G	628	622	0.797	1.032 [0.844–1.262]
T	268	274		0.969 [0.792–1.185]
rs17000900 (MxA)
Genotype
AA	12	13	0.999	0.921 [0.414–1.988]
AC	112	114	0.939	0.977 [0.726–1.314]
CC	324	321	0.882	1.034 [0.775–1.380]
Allele
A	136	140	0.844	0.966 [0.746–1.250]
C	760	756		1.035 [0.800–1.340]
rs9982944 (MxB)
Genotype
AA	37	40	0.812	0.918 [0.576–1.452]
AG	204	222	0.255	0.851 [0.656–1.103]
GG	207	186	0.178	1.210 [0.930–1.576]
Allele
A	278	302	0.246	0.885 [0.725–1.079]
G	618	594		1.130 [0.926–1.380]
rs408825 (MxB)
Genotype
CC	19	18	0.999	1.058 [0.560–2.024]
CT	126	131	0.768	0.947 [0.712–1.260]
TT	303	299	0.831	1.041 [0.784–1.370]
Allele
C	164	167	0.903	0.978 [0.771–1.240]
T	732	729		1.022 [0.806–1.297]
rs2838029 (MxB)
Genotype
AA	1	5	0.219	0.198 [0.017–1.434]
AG	60	58	0.921	1.040 [0.702–1.544]
GG	387	385	0.923	1.038 [0.712–1.516]
Allele
A	62	68	0.649	0.905 [0.635–1.284]
G	834	828		1.105 [0.779–1.576]